Modified clot waveform analysis to measure plasma coagulation potential in the presence of the anti‐factor IXa/factor X bispecific antibody emicizumab: comment
Author(s): ,
T. Matsumoto
Affiliations:
Division of Blood Transfusion Medicine and Cell Therapy, Mie University Hospital, Tsu, Japan
,
H. Wada
Affiliations:
Department of Molecular and Laboratory Medicine, Mie University Graduate School of Medicine, Tsu, Japan
Correspondence: Hideo Wada, Department of Laboratory Medicine, Mie University Graduate School of Medicine, 2‐174 Edobashi, Tsu‐City, Mie 514‐8507, Japan|Tel.: +81 59 232 1111|E‐mail: wadahide@clin.medic.mie-u.ac.jp
,
H. Toyoda
Affiliations:
Department of Pediatrics, Mie University Graduate School of Medicine, Tsu, Japan
,
M. Hirayama
Affiliations:
Department of Pediatrics, Mie University Graduate School of Medicine, Tsu, Japan
,
Y. Yamashita
Affiliations:
Department of Hematology and Oncology, Mie University Graduate School of Medicine, Tsu, Japan
N. Katayama
Affiliations:
Department of Hematology and Oncology, Mie University Graduate School of Medicine, Tsu, Japan
ISTH Academy. Wada H. Aug 2, 2018; 227421
Hideo Wada
Hideo Wada

Access to Premium content is currently a membership benefit.


Click here to join ISTH or renew your membership.

Discussion Forum (0)
Rate & Comment (0)
Code of conduct/disclaimer available in General Terms & Conditions

By continuing to browse or by clicking “Accept Terms & all Cookies”, you agree to the storing of third-party cookies on your device to enhance your user experience and agree to the user terms and conditions of this learning management system (LMS).

Cookie Settings
Accept Terms & all Cookies